Study of the Safety, Pharmacokinetics and Efficacy of EDO-S101, in Patients With Advanced Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Small-cell Lung Cancer|Soft Tissue Sarcoma|Triple-negative Breast Cancer|Ovarian Cancer|Endometrial Cancer
Interventions: DRUG: Tinostamustine (EDO-S101)
Sponsor: Mundipharma Research Limited